<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7132016/results/search/disease/results.xml">
  <result pre="[3], [4], [5], [6], [7], [8], *Correspondence to: Ming-Hua Zheng," exact="NAFLD" post="Research Center, Department of Hepatology, the First Affiliated Hospital"/>
  <result pre="the Journal’s website at http://www.jcthnet.com&quot;. Abstract Abstract The outbreak of" exact="coronavirus disease" post="2019 (COVID-19), caused by the severe acute respiratory syndrome"/>
  <result pre="Journal’s website at http://www.jcthnet.com&quot;. Abstract Abstract The outbreak of coronavirus" exact="disease" post="2019 (COVID-19), caused by the severe acute respiratory syndrome"/>
  <result pre="outbreak of coronavirus disease 2019 (COVID-19), caused by the severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2), has attracted increasing worldwide"/>
  <result pre="of coronavirus disease 2019 (COVID-19), caused by the severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2), has attracted increasing worldwide attention."/>
  <result pre="coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2), has attracted increasing worldwide attention. Cases"/>
  <result pre="syndrome coronavirus 2 (SARS-CoV-2), has attracted increasing worldwide attention. Cases" exact="of liver" post="damage or dysfunction (mainly characterized by moderately elevated serum"/>
  <result pre="Cases of liver damage or dysfunction (mainly characterized by moderately" exact="elevated serum" post="aspartate aminotransferase levels) have been reported among patients with"/>
  <result pre="whether the COVID-19-related liver damage/dysfunction is due mainly to the" exact="viral infection" post="per se or other coexisting conditions, such as the"/>
  <result pre="the COVID-19-related liver damage/dysfunction is due mainly to the viral" exact="infection" post="per se or other coexisting conditions, such as the"/>
  <result pre="the use of potentially hepatotoxic drugs and the coexistence of" exact="systemic" post="inflammatory response, respiratory distress syndrome-induced hypoxia, and multiple organ"/>
  <result pre="potentially hepatotoxic drugs and the coexistence of systemic inflammatory response," exact="respiratory" post="distress syndrome-induced hypoxia, and multiple organ dysfunction. Based on"/>
  <result pre="and control measures for COVID-19. COVID-19 Liver dysfunction SARS-CoV-2 Introduction" exact="Severe" post="acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a"/>
  <result pre="control measures for COVID-19. COVID-19 Liver dysfunction SARS-CoV-2 Introduction Severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a serious"/>
  <result pre="measures for COVID-19. COVID-19 Liver dysfunction SARS-CoV-2 Introduction Severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) has become a serious threat"/>
  <result pre="for COVID-19. COVID-19 Liver dysfunction SARS-CoV-2 Introduction Severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) has become a serious threat to"/>
  <result pre="the virus appears to be only partially similar to severe" exact="acute" post="respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus,"/>
  <result pre="virus appears to be only partially similar to severe acute" exact="respiratory" post="syndrome coronavirus and Middle East respiratory syndrome coronavirus, all"/>
  <result pre="appears to be only partially similar to severe acute respiratory" exact="syndrome" post="coronavirus and Middle East respiratory syndrome coronavirus, all of"/>
  <result pre="similar to severe acute respiratory syndrome coronavirus and Middle East" exact="respiratory" post="syndrome coronavirus, all of these viral infections are responsible"/>
  <result pre="to severe acute respiratory syndrome coronavirus and Middle East respiratory" exact="syndrome" post="coronavirus, all of these viral infections are responsible for"/>
  <result pre="coronavirus and Middle East respiratory syndrome coronavirus, all of these" exact="viral" post="infections are responsible for severe and potentially lethal acute"/>
  <result pre="and Middle East respiratory syndrome coronavirus, all of these viral" exact="infections" post="are responsible for severe and potentially lethal acute respiratory"/>
  <result pre="these viral infections are responsible for severe and potentially lethal" exact="acute" post="respiratory syndromes in humans.3 Unfortunately, to date, there are"/>
  <result pre="viral infections are responsible for severe and potentially lethal acute" exact="respiratory" post="syndromes in humans.3 Unfortunately, to date, there are no"/>
  <result pre="The world and China map showing the geographical distribution of" exact="coronavirus disease" post="2019 (COVID-19) is shown in Figure 1; the cut-off"/>
  <result pre="world and China map showing the geographical distribution of coronavirus" exact="disease" post="2019 (COVID-19) is shown in Figure 1; the cut-off"/>
  <result pre="extraction of March 5, 2020. Surprisingly, in addition to the" exact="acute" post="respiratory symptoms, patients with COVID-19 also have varying degrees"/>
  <result pre="of March 5, 2020. Surprisingly, in addition to the acute" exact="respiratory" post="symptoms, patients with COVID-19 also have varying degrees of"/>
  <result pre="acute respiratory symptoms, patients with COVID-19 also have varying degrees" exact="of liver" post="damage/dysfunction. For example, Chen et al.5 showed that more"/>
  <result pre="(ALT) or aspartate aminotransferase (AST) levels; one patient had severely" exact="elevated serum" post="aminotransferases (ALT of 7590 U/L, AST of 1445 U/L).5"/>
  <result pre="and case series covering COVID-19 patients, with a clear description" exact="of liver" post="function tests and results. All case reports without any"/>
  <result pre="Year Country Age (years) Sex AST (IU/L) ALT (IU/L) COVID-19" exact="Disease" post="severity Prior history of liver diseases Drugs Antibiotic drugs"/>
  <result pre="Sex AST (IU/L) ALT (IU/L) COVID-19 Disease severity Prior history" exact="of liver" post="diseases Drugs Antibiotic drugs Antiviral drugs Antifungal drugs Zhang"/>
  <result pre="drugs Antifungal drugs Zhang YH, 20206 China (Haikou) 3 months" exact="Female" post="Normal Normal Non-severe No Azithromycin, Ceftazidime Paramivir NA Chen"/>
  <result pre="Antifungal drugs Zhang YH, 20206 China (Haikou) 3 months Female" exact="Normal" post="Normal Non-severe No Azithromycin, Ceftazidime Paramivir NA Chen F,"/>
  <result pre="drugs Zhang YH, 20206 China (Haikou) 3 months Female Normal" exact="Normal" post="Non-severe No Azithromycin, Ceftazidime Paramivir NA Chen F, 20207"/>
  <result pre="Ceftazidime Paramivir NA Chen F, 20207 China (Wuhan) 1 Male" exact="Normal" post="Normal Severe NA Meropenem, Linezolid, Oseltamivir NA NA Cai"/>
  <result pre="Paramivir NA Chen F, 20207 China (Wuhan) 1 Male Normal" exact="Normal" post="Severe NA Meropenem, Linezolid, Oseltamivir NA NA Cai JH,"/>
  <result pre="NA Chen F, 20207 China (Wuhan) 1 Male Normal Normal" exact="Severe" post="NA Meropenem, Linezolid, Oseltamivir NA NA Cai JH, 20208"/>
  <result pre="NA AST: aspartate aminotransferase. ALT: alanine aminotransferase. Liver diseases: any" exact="liver disease" post="that can cause serum liver enzyme changes, such as"/>
  <result pre="AST: aspartate aminotransferase. ALT: alanine aminotransferase. Liver diseases: any liver" exact="disease" post="that can cause serum liver enzyme changes, such as"/>
  <result pre="disease that can cause serum liver enzyme changes, such as" exact="viral hepatitis," post="autoimmune hepatitis, etc. NA: not available. Normal ranges for"/>
  <result pre="can cause serum liver enzyme changes, such as viral hepatitis," exact="autoimmune" post="hepatitis, etc. NA: not available. Normal ranges for AST"/>
  <result pre="such as viral hepatitis, autoimmune hepatitis, etc. NA: not available." exact="Normal" post="ranges for AST and ALT: AST &amp;lt; 40 IU/L"/>
  <result pre="&amp;lt; 40 IU/L and ALT &amp;lt; 40 IU/L. *Standard deviation" exact="of liver" post="enzyme fluctuations during hospitalization Table 2. Main characteristics related"/>
  <result pre="enzyme fluctuations during hospitalization Table 2. Main characteristics related to" exact="liver disease" post="in patients with COVID-19 infection in different Chinese regions"/>
  <result pre="fluctuations during hospitalization Table 2. Main characteristics related to liver" exact="disease" post="in patients with COVID-19 infection in different Chinese regions"/>
  <result pre="Main characteristics related to liver disease in patients with COVID-19" exact="infection" post="in different Chinese regions based on a series of"/>
  <result pre="Abnormal ALT (%) ALT (IU/L) Male, n (%) Age (years)" exact="Disease" post="severity History of liver diseases (%) Drugs Severe (%)"/>
  <result pre="ALT (IU/L) Male, n (%) Age (years) Disease severity History" exact="of liver" post="diseases (%) Drugs Severe (%) Non-severe (%) Antibiotic drugs"/>
  <result pre="Age (years) Disease severity History of liver diseases (%) Drugs" exact="Severe" post="(%) Non-severe (%) Antibiotic drugs (%) Antiviral drugs (%)"/>
  <result pre="aminotransferase; ALT, alanine aminotransferase; NA, not available. Liver diseases: any" exact="liver disease" post="that can cause liver enzyme changes, such as viral"/>
  <result pre="ALT, alanine aminotransferase; NA, not available. Liver diseases: any liver" exact="disease" post="that can cause liver enzyme changes, such as viral"/>
  <result pre="liver disease that can cause liver enzyme changes, such as" exact="viral hepatitis," post="autoimmune hepatitis, etc. Normal range for AST and ALT:"/>
  <result pre="that can cause liver enzyme changes, such as viral hepatitis," exact="autoimmune" post="hepatitis, etc. Normal range for AST and ALT: AST"/>
  <result pre="liver enzyme changes, such as viral hepatitis, autoimmune hepatitis, etc." exact="Normal" post="range for AST and ALT: AST &amp;lt; 40 IU/L"/>
  <result pre="plausible to speculate that there may have been a higher" exact="viral" post="load of COVID-19 in exposed patients in Wuhan, where"/>
  <result pre="load of COVID-19 in exposed patients in Wuhan, where the" exact="infection" post="began and was concentrated in a greater proportion of"/>
  <result pre="and outside Wuhan. Sex distribution of COVID-19-related liver dysfunction A" exact="total" post="of six case series reporting the percentage of abnormal"/>
  <result pre="from 3 months to 7 years, whereas the age of" exact="adult" post="patients ranged from 35 to 56 years. None of"/>
  <result pre="hypothesize that older age is associated with a higher likelihood" exact="of liver" post="damage/dysfunction. However, further studies are needed to confirm this"/>
  <result pre="known. Some studies have suggested that SARS-CoV-2 predominantly enters alveolar" exact="epithelial" post="cells through the human ACE2 receptor.19,20 Therefore, the lung"/>
  <result pre="SARS-CoV-2 infection. However, previous studies have found that bile duct" exact="epithelial" post="cells may also express ACE2 receptor at a concentration"/>
  <result pre="higher than in hepatocytes and these findings suggest that SARS-CoV-2" exact="infection" post="might also cause bile duct epithelial cell damage.21,22 However,"/>
  <result pre="findings suggest that SARS-CoV-2 infection might also cause bile duct" exact="epithelial" post="cell damage.21,22 However, significant increases in circulating levels of"/>
  <result pre="assume that COVID-19-related liver dysfunction is more likely due to" exact="secondary" post="liver damage than the use of hepatotoxic therapies or"/>
  <result pre="than the use of hepatotoxic therapies or the coexistence of" exact="systemic" post="inflammatory response, respiratory distress syndrome-induced hypoxia, or multiple organ"/>
  <result pre="of hepatotoxic therapies or the coexistence of systemic inflammatory response," exact="respiratory" post="distress syndrome-induced hypoxia, or multiple organ dysfunction. Drugs During"/>
  <result pre="damage or induce liver failure.23 It is known that an" exact="acute" post="ingestion of &amp;gt;7.5 to 10 g of acetaminophen in"/>
  <result pre="oseltamivir, abidol or lopinavir, which may have some hepatotoxic effects." exact="Systemic" post="inflammatory response syndrome Although many COVID-19 patients were not"/>
  <result pre="lopinavir, which may have some hepatotoxic effects. Systemic inflammatory response" exact="syndrome" post="Although many COVID-19 patients were not too unwell, this"/>
  <result pre="syndrome Although many COVID-19 patients were not too unwell, this" exact="infection" post="in some patients has resulted in sudden deterioration, ending"/>
  <result pre="the critically ill COVID-19 patients.26 The so-called inflammatory &quot;storm&quot;, or" exact="systemic" post="inflammatory response syndrome, is strongly related to activation of"/>
  <result pre="as TLRs. At the same time, T-lymphocyte depletion cannot control" exact="viral" post="and bacterial infections, thereby activating multiple inflammatory signaling pathways,"/>
  <result pre="At the same time, T-lymphocyte depletion cannot control viral and" exact="bacterial infections," post="thereby activating multiple inflammatory signaling pathways, which lead to"/>
  <result pre="multiple inflammatory signaling pathways, which lead to macrophage activation and" exact="secondary" post="inflammatory reactions. Subsequently, when more inflammatory cytokines are released,"/>
  <result pre="liver, heart, and kidneys. Fig. 3. Schematic diagram showing the" exact="systemic" post="inflammatory response syndrome induced by SARS-CoV2. After the SARS-CoV-2"/>
  <result pre="kidneys. Fig. 3. Schematic diagram showing the systemic inflammatory response" exact="syndrome" post="induced by SARS-CoV2. After the SARS-CoV-2 infection, pathogenic T"/>
  <result pre="dysfunction Hypoxia and shock induced by COVID-19-related complications (such as" exact="respiratory" post="distress syndrome, systemic inflammatory response syndrome, and multiple organ"/>
  <result pre="shock induced by COVID-19-related complications (such as respiratory distress syndrome," exact="systemic" post="inflammatory response syndrome, and multiple organ failure) may also"/>
  <result pre="response syndrome, and multiple organ failure) may also cause hepatic" exact="ischemia" post="and hypoxia-reperfusion dysfunction. Experimental data showed that hepatic cell"/>
  <result pre="that hepatic cell death and inflammatory cell infiltration caused by" exact="hypoxia" post="can be seen both in vivo and in vitro"/>
  <result pre="seen both in vivo and in vitro models of hepatic" exact="ischemia" post="and hypoxia.29 This suggests that oxygen reduction and lipid"/>
  <result pre="causing liver damage.30 All the aforementioned findings suggest that pneumonia-associated" exact="hypoxia" post="is one of the most important factors causing secondary"/>
  <result pre="pneumonia-associated hypoxia is one of the most important factors causing" exact="secondary" post="liver injury in COVID-19 patients. In summary, the COVID-19-related"/>
  <result pre="COVID-19-related liver dysfunction may be considered as the result of" exact="secondary" post="liver damage caused mainly by several factors, such as"/>
  <result pre="several factors, such as the use of potentially hepatotoxic drugs," exact="systemic" post="inflammatory response, respiratory distress syndrome-induced hypoxia, and multiple organ"/>
  <result pre="as the use of potentially hepatotoxic drugs, systemic inflammatory response," exact="respiratory" post="distress syndrome-induced hypoxia, and multiple organ failure. In addition,"/>
  <result pre="is patient isolation and supportive medical care where necessary, including" exact="pulmonary" post="ventilation and prevention of the underlying inflammatory &quot;storm&quot; as"/>
  <result pre="is highly expressed in human lung tissues, gastrointestinal tract, liver," exact="vascular" post="endothelial cells, and arterial smooth muscle cells.33 In addition,"/>
  <result pre="tissues, gastrointestinal tract, liver, vascular endothelial cells, and arterial smooth" exact="muscle" post="cells.33 In addition, skin, nasal cavity, and oral mucosa"/>
  <result pre="smooth muscle cells.33 In addition, skin, nasal cavity, and oral" exact="mucosa" post="basal cells also express the ACE2 receptor.27 All organs"/>
  <result pre="and angiotensin-II-receptor antagonists might be used not only for treating" exact="high blood pressure" post="but also for reducing systemic inflammatory response and improving"/>
  <result pre="only for treating high blood pressure but also for reducing" exact="systemic" post="inflammatory response and improving patient mortality.35 Recently, Chen et"/>
  <result pre="is one of the first-line drugs for anti-inflammatory protection in" exact="liver disease," post="and it has been used in clinical practice for"/>
  <result pre="the root of the licorice plant. ACE2 is a cellular" exact="type I" post="membrane protein that is mostly expressed in the lungs,"/>
  <result pre="of infected patients with abnormal liver function test results (mainly" exact="elevated serum" post="AST levels) is greater than that observed in regions"/>
  <result pre="in regions where a smaller proportion of cases of COVID-19" exact="infection" post="in the population have occurred. (2) The proportion of"/>
  <result pre="population have occurred. (2) The proportion of infected patients with" exact="elevated serum" post="transaminase levels is higher in adults than in children"/>
  <result pre="infected with COVID-19. For those patients with a pre-existing history" exact="of liver" post="diseases (especially older patients), special attention should be paid"/>
  <result pre="use of appropriate hepatoprotective therapies, especially in patients with pre-existing" exact="liver disease," post="in order to attenuate the potentially deleterious impact of"/>
  <result pre="damage/dysfunction. References References 1ZhuNZhangDWangWLiXYangBSongJet al.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med202038272773310.1056/NEJMoa200101731978945 2LiQGuanXWuPWangXZhouLTongYet al.Early transmission"/>
  <result pre="injury in COVID-19: management and challengesLancet Gastroenterol Hepatol202010.1016/S2468-1253(20)30057-1 4collab: WHOCoronavirus" exact="disease" post="2019 (COVID-19) situation report-492020Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200309-sitrep-49-covid-19.pdf?sfvrsn=70dabe61_4 5ChenNZhouMDongXQuJGongFHanYet al.Epidemiological and"/>
  <result pre="al.Epidemiological and clinical characteristics of 99 cases of 2019 novel" exact="coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 6ZhangYHLinDJXiaoMFWangJCWeiYLeiZXet al.[2019-novel coronavirus"/>
  <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 6ZhangYHLinDJXiaoMFWangJCWeiYLeiZXet al.[2019-novel coronavirus"/>
  <result pre="coronavirus pneumonia in Wuhan, China: a descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 6ZhangYHLinDJXiaoMFWangJCWeiYLeiZXet al.[2019-novel" exact="coronavirus infection" post="in a three-month-old baby]Zhonghua Er Ke Za Zhi202058E00610.3760/cma.j.issn.0578-1310.2020.000632043842 7ChenFLiuZSZhangFRXiongRHChenYChengXFet"/>
  <result pre="pneumonia in Wuhan, China: a descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 6ZhangYHLinDJXiaoMFWangJCWeiYLeiZXet al.[2019-novel coronavirus" exact="infection" post="in a three-month-old baby]Zhonghua Er Ke Za Zhi202058E00610.3760/cma.j.issn.0578-1310.2020.000632043842 7ChenFLiuZSZhangFRXiongRHChenYChengXFet"/>
  <result pre="baby]Zhonghua Er Ke Za Zhi202058E00610.3760/cma.j.issn.0578-1310.2020.000632043842 7ChenFLiuZSZhangFRXiongRHChenYChengXFet al.[First case of severe" exact="childhood" post="novel coronavirus pneumonia in China]Zhonghua Er Ke Za Zhi202058E00510.3760/cma.j.issn.0578-1310.2020.000532045966"/>
  <result pre="Ke Za Zhi202058E00610.3760/cma.j.issn.0578-1310.2020.000632043842 7ChenFLiuZSZhangFRXiongRHChenYChengXFet al.[First case of severe childhood novel" exact="coronavirus pneumonia" post="in China]Zhonghua Er Ke Za Zhi202058E00510.3760/cma.j.issn.0578-1310.2020.000532045966 8CaiJHWangXSGeYLXiaAMChangHLTianHet al.[First case"/>
  <result pre="Za Zhi202058E00610.3760/cma.j.issn.0578-1310.2020.000632043842 7ChenFLiuZSZhangFRXiongRHChenYChengXFet al.[First case of severe childhood novel coronavirus" exact="pneumonia" post="in China]Zhonghua Er Ke Za Zhi202058E00510.3760/cma.j.issn.0578-1310.2020.000532045966 8CaiJHWangXSGeYLXiaAMChangHLTianHet al.[First case"/>
  <result pre="Er Ke Za Zhi202058E00510.3760/cma.j.issn.0578-1310.2020.000532045966 8CaiJHWangXSGeYLXiaAMChangHLTianHet al.[First case of 2019 novel" exact="coronavirus infection" post="in children in Shanghai]Zhonghua Er Ke Za Zhi202058868710.3760/cma.j.issn.0578-1310.2020.02.00232102141 9HolshueMLDeBoltCLindquistSLofyKHWiesmanJBruceHet"/>
  <result pre="Ke Za Zhi202058E00510.3760/cma.j.issn.0578-1310.2020.000532045966 8CaiJHWangXSGeYLXiaAMChangHLTianHet al.[First case of 2019 novel coronavirus" exact="infection" post="in children in Shanghai]Zhonghua Er Ke Za Zhi202058868710.3760/cma.j.issn.0578-1310.2020.02.00232102141 9HolshueMLDeBoltCLindquistSLofyKHWiesmanJBruceHet"/>
  <result pre="in Canada, presenting as mild pneumoniaLancet202039573410.1016/S0140-6736(20)30370-632061312 11GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of" exact="coronavirus disease" post="2019 in ChinaN Engl J Med202010.1056/NEJMoa2002032 12XuXWWuXXJiangXGXuKJYingLJMaCLet al.Clinical findings"/>
  <result pre="Canada, presenting as mild pneumoniaLancet202039573410.1016/S0140-6736(20)30370-632061312 11GuanWJNiZYHuYLiangWHOuCQHeJXet al.Clinical characteristics of coronavirus" exact="disease" post="2019 in ChinaN Engl J Med202010.1056/NEJMoa2002032 12XuXWWuXXJiangXGXuKJYingLJMaCLet al.Clinical findings"/>
  <result pre="al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected" exact="pneumonia" post="in Wuhan, ChinaJAMA202010.1001/jama.2020.1585 15PanFYeTSunPGuiSLiangBLiLet al.Time course of lung changes"/>
  <result pre="in Wuhan, ChinaJAMA202010.1001/jama.2020.1585 15PanFYeTSunPGuiSLiangBLiLet al.Time course of lung changes on" exact="chest" post="CT during recovery from 2019 novel coronavirus (COVID-19) pneumoniaRadiology202020037010.1148/radiol.202020037032053470"/>
  <result pre="(COVID-19) pneumoniaRadiology202020037010.1148/radiol.202020037032053470 16LiuCJiangZCShaoCXZhangHGYueHMChenZHet al.[Preliminary study of the relationship between novel" exact="coronavirus pneumonia" post="and liver function damage: a multicenter study]Zhonghua Gan Zang"/>
  <result pre="pneumoniaRadiology202020037010.1148/radiol.202020037032053470 16LiuCJiangZCShaoCXZhangHGYueHMChenZHet al.[Preliminary study of the relationship between novel coronavirus" exact="pneumonia" post="and liver function damage: a multicenter study]Zhonghua Gan Zang"/>
  <result pre="18ChenHGuoJWangCLuoFYuXZhangWet al.Clinical characteristics and intrauterine vertical transmission potential of COVID-19" exact="infection" post="in nine pregnant women: a retrospective review of medical"/>
  <result pre="20XuHZhongLDengJPengJDanHZengXet al.High expression of ACE2 receptor of 2019-nCoV on the" exact="epithelial" post="cells of oral mucosaInt J Oral Sci202012810.1038/s41368-020-0074-x32094336 21ChaiXHuLZhangYHanWLuZKeAet al.Specific"/>
  <result pre="cause liver damage after 2019-nCoV infectionbioRxiv2020v110.1101/2020.02.03.931766 22GuanGWGaoLWangJWWenXJMaoTHPengSWet al.[Exploring the mechanism" exact="of liver" post="enzyme abnormalities in patients with novel coronavirus-infected pneumonia]Zhonghua Gan"/>
  <result pre="Bing Za Zhi202028E00210.3760/cma.j.issn.1007-3418.2020.02.002 23XuZShiLWangYZhangJHuangLZhangCet al.Pathological findings of COVID-19 associated with" exact="acute" post="respiratory distress syndromeLancet Respir Med202010.1016/s2213-2600(20)30076-x 24HodgmanMJGarrardARA review of acetaminophen"/>
  <result pre="Za Zhi202028E00210.3760/cma.j.issn.1007-3418.2020.02.002 23XuZShiLWangYZhangJHuangLZhangCet al.Pathological findings of COVID-19 associated with acute" exact="respiratory" post="distress syndromeLancet Respir Med202010.1016/s2213-2600(20)30076-x 24HodgmanMJGarrardARA review of acetaminophen poisoningCrit"/>
  <result pre="SARS and MERS epidemicAsian Pac J Allergy Immunol2020381910.12932/ap-200220-077232105090 27KlimstraWBRymanKDBernardKANguyenKBBironCAJohnstonREInfection of" exact="neonatal" post="mice with sindbis virus results in a systemic inflammatory"/>
  <result pre="27KlimstraWBRymanKDBernardKANguyenKBBironCAJohnstonREInfection of neonatal mice with sindbis virus results in a" exact="systemic" post="inflammatory response syndromeJ Virol199973103871039810559357 28TarteySTakeuchiOPathogen recognition and Toll-like receptor"/>
  <result pre="hepatic ischemia-reperfusion injuryNat Med201824738310.1038/nm.445129227475 31ZhangZLiXZhangWShiZLZhengZWangTClinical features and treatment of 2019-nCov" exact="pneumonia" post="patients in Wuhan: report of a couple casesVirol Sin202010.1007/s12250-020-00203-8"/>
  <result pre="focus on angiotensin-(1-7)Physiol Rev20189850555310.1152/physrev.00023.201629351514 34DingYWangHShenHLiZGengJHanHet al.The clinical pathology of severe" exact="acute" post="respiratory syndrome (SARS): a report from ChinaJ Pathol200320028228910.1002/path.144012845623 35SunMLYangJMSunYPSuGH[Inhibitors"/>
  <result pre="on angiotensin-(1-7)Physiol Rev20189850555310.1152/physrev.00023.201629351514 34DingYWangHShenHLiZGengJHanHet al.The clinical pathology of severe acute" exact="respiratory" post="syndrome (SARS): a report from ChinaJ Pathol200320028228910.1002/path.144012845623 35SunMLYangJMSunYPSuGH[Inhibitors of"/>
  <result pre="angiotensin-(1-7)Physiol Rev20189850555310.1152/physrev.00023.201629351514 34DingYWangHShenHLiZGengJHanHet al.The clinical pathology of severe acute respiratory" exact="syndrome" post="(SARS): a report from ChinaJ Pathol200320028228910.1002/path.144012845623 35SunMLYangJMSunYPSuGH[Inhibitors of RAS"/>
  <result pre="compounds for preventing 2019-nCoV infectionPreprints20202020010358(v3)10.20944/preprints202001.0358.v3 37LiJYCaoHYLiuPChengGHSunMYGlycyrrhizic acid in the treatment" exact="of liver" post="diseases: literature reviewBiomed Res Int2014201487213910.1155/2014/87213924963489 38YanRZhangYLiYXiaLZhouQStructure of dimeric full-length"/>
  <result pre="angiotensin converting enzyme ALT alanine aminotransferase AST aspartate aminotransferase COVID-19" exact="coronavirus disease" post="2019 SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 TLR"/>
  <result pre="converting enzyme ALT alanine aminotransferase AST aspartate aminotransferase COVID-19 coronavirus" exact="disease" post="2019 SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 TLR"/>
  <result pre="aminotransferase AST aspartate aminotransferase COVID-19 coronavirus disease 2019 SARS-CoV-2 severe" exact="acute" post="respiratory syndrome coronavirus 2 TLR toll-like receptor"/>
  <result pre="AST aspartate aminotransferase COVID-19 coronavirus disease 2019 SARS-CoV-2 severe acute" exact="respiratory" post="syndrome coronavirus 2 TLR toll-like receptor"/>
  <result pre="aspartate aminotransferase COVID-19 coronavirus disease 2019 SARS-CoV-2 severe acute respiratory" exact="syndrome" post="coronavirus 2 TLR toll-like receptor"/>
 </snippets>
</snippetsTree>
